Lee, Elizabeth K <br/><br/>
Results of an abbreviated phase II study of AKT inhibitor MK-2206 in the treatment of recurrent platinum-resistant high grade serous ovarian, fallopian tube, or primary peritoneal carcinoma (NCT 01283035).  [electronic resource] 

 -  Gynecologic oncology reports  May 2020 
 - 100546 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>2352-5789 
<br/><br/><label>Standard No.: </label>10.1016/j.gore.2020.100546  doi